Study of the Impact of Exposure to Outdoor and Indoor Pollutants in Patients With Asthma

NCT ID: NCT05525169

Last Updated: 2022-12-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-11-15

Study Completion Date

2025-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The project is to measure exposure to outdoor and indoor air pollutants in asthma patients in order to show a possible association between variation in pollutant exposure and the occurrence of exacerbations in these patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Asthma is a chronic airway disease affecting between 6% and 7% of the French adult population. Asthma is responsible for nearly 1000 deaths each year in France. Air pollution (indoor and outdoor) is responsible for 7 million deaths each year according to the World Health Organization (WHO) assessment published in 2018, including 65,000 in France. Studies monitoring exposure to indoor air pollutants are few in number in asthmatic patients. Very little research has been devoted to continuous monitoring of indoor air quality in homes. Our hypothesis is that variation in exposure to indoor air pollutants, in relation to outdoor air, would have an impact on the occurrence of exacerbations in asthmatic patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient over 18 years of age,
* Patient with a confirmed diagnosis of asthma for at least 12 months as defined by the investigator,
* Patient with at least 4 asthma exacerbations in the last year
* Patient sleeping at least 6 nights per week in the same home

Exclusion Criteria

* Patient who is an active smoker or living with an active smoker,
* Patient with a diagnosis of COPD, ABPA or associated pulmonary fibrosis,
* Patient with an asthma exacerbation within 15 days prior to the inclusion visit,
* Patient with known occupational exposure,
* Patient living in a dwelling that does not allow the installation of sensors (inability to connect the sensor to the power supply, no location for the outdoor sensor...)
* Patient who plans to move in the next 6 months,
* Patient with a life expectancy of less than 6 months,
* Patient who has someone living in their household also included in EXAP,
* Patient who lives in an apartment and does not have a balcony or space for the outdoor sensor,
* Pregnant or breastfeeding women,
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nantes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

François-Xavier Blanc, PU-PH

Role: PRINCIPAL_INVESTIGATOR

Nantes University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Nantes

Nantes, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

François-Xavier Blanc, PU-PH

Role: CONTACT

02 40 16 53 33

Megguy Bernard

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

François-Xavier Blanc, PU-PH

Role: primary

02 40 16 53 33

Megguy Bernard

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC22_0115

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Phenotyping and Classifying Asthma Exacerbations
NCT05304039 ACTIVE_NOT_RECRUITING